The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.
January 2nd 2026
Medicare HIV cases are projected to double by 2035, with cumulative costs reaching $195.6 billion and creating critical challenges for federal funding.
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
View More
Payment for Pharmacist Services: 2025 Update
1.0 Credit / General Pharmacy, Health Equity, Diversity & Inclusion, Law
View More
Immunotherapy Is Safe, Effective in Patients With Cancer Living With HIV
February 12th 2019A systematic review has found that immune checkpoint inhibitors are safe in patients with cancer living with HIV, and that these patients have similar objective response rates for certain cancers that have been seen in uninfected patients with cancer.
Read More
HIV Experts Across HHS Outline Plan for Ending HIV Epidemic Within 10 Years
February 7th 2019Following President Trump’s second State of the Union address, where he announced plans to end the HIV epidemic, HIV experts from across HHS outlined a comprehensive plan of action focusing on diagnosis, treatment, prevention, and response.
Read More
Trump Highlights New Initiatives for Childhood Cancer, HIV in State of the Union
February 6th 2019During his second State of the Union address, President Trump highlighted past bipartisan accomplishments, such as legislation to confront the opioid crisis, but also outlined future priorities, such as addressing the cost of healthcare and prescription drugs.
Read More
What We're Reading: Trump May Include HIV Plan in Speech; Judge Tosses ACA Suit; CF Treatment Gaps
February 4th 2019While President Trump's State of the Union address is not finalized, he may plan to unveil a promise to end HIV transmission in America by 2030; a federal judge dismissed a lawsuit brought by Maryland that claimed the Trump administration is failing to enforce the Affordable Care Act; new cystic fibrosis (CF) treatments targeting the genetic mutations that cause the disease help about 90% of patients, meaning that 10% are still waiting for a cutting-edge therapy.
Read More
When the American College of Cardiology/American Heart Association (ACC/AHA) released new cholesterol guidelines in 2013, replacing older guidelines and changing statin eligibility, more patients with HIV became recommended for statin therapy. However, many patients are still not recommended for or prescribed the treatment.
Read More
Researchers Say They Can Now Accurately Measure HIV Reservoirs
January 30th 2019Being able to accurately measure HIV reservoirs that remain in the body even during viral suppression is the first step to being able to destroy these reservoirs and, potentially, cure the infection. Researchers say they've created a new technique that will allow them to do so.
Read More
NIH Researchers Say the Science Is Clear: Undetectable Equals Untransmittable in HIV
January 16th 2019Researchers from the National Institutes of Health (NIH)’s National Institute of Allergy and Infectious Diseases reviewed clinical trials and cohort studies validating the concept that people living with HIV who have achieved viral suppression can not sexually transmit HIV.
Read More
Damaged Immune Receptor Could Lead to More Severe Comorbidities in HIV, Study Finds
January 14th 2019While treatment for HIV has made tremendous strides over the past few decades, many patients with the infection still struggle with comorbidities such as chronic inflammation, diabetes, and cardiovascular problems, among others. In a recent study, researchers at Michigan State University sought to understand why patients with HIV develop such complications.
Read More
Following Discrimination Allegations, Insurer Will Stop Denying Coverage Based on PrEP Usage
January 11th 2019Mutual of Omaha has agreed to no longer deny life insurance and long-term insurance to people using Truvada for HIV prevention following allegations of discrimination in 2 separate settlements.
Read More
State Data Show Racial/Ethnic Disparities in HIV, Syphilis Diagnoses Among MSM
January 8th 2019Using state-level surveillance data of reported HIV and syphilis cases among men who have sex with men (MSM), researchers found a widely disparate impact of HIV and syphilis among black and Hispanic MSM compared with white MSM.
Read More
Single-Tablet Regimens Produce Better HIV Virologic Response Than Multiple-Tablet Regimens
December 26th 2018According to a new study, single-tablet regimens may provide better virologic response and control than multiple-tablet regimens for people living with HIV, likely due to a lower pill burden and, subsequently, better medication adherence.
Read More
Diabetes, Cancer Interviews Among Most-Watched Videos of 2018
December 20th 2018Throughout the year, The American Journal of Managed Care® (AJMC®) offered a number of video programs, including Peer Exchange discussions and interviews, on a range of topics. Here are the most-watched videos published by AJMC® in 2018.
Read More
NIH Announces Funding for HIV Treatment, Prevention Research in Vulnerable Southern Counties
December 13th 2018The National Institutes of Health (NIH) said that it will fund a series of collaborations with medical research institutions in the region as part of a new initiative that will expand ongoing research at the NIH-funded Centers for AIDS Research, a group of HIV-focused research institutions focused on reducing the burden of HIV domestically and globally.
Read More
HIV-2 Just as Deadly as HIV-1, but at a Slower Rate
December 6th 2018A recent study compared the time to AIDS and mortality and the CD4 T-cell dynamics between HIV-1 and HIV-2, finding that both groups have a high probability of developing and dying from AIDS without antiretroviral treatment.
Read More
This Week in Managed Care: November 30, 2018
November 30th 2018This week, the top managed care news included a CMS plan for changes in drug coverage that brought a wave of criticism; a government task force recommended more people at risk for HIV take pre-exposure prophylaxis, known as PrEP; the American College of Cardiology issued an Expert Consensus Pathway on treatment of patients with type 2 diabetes and atherosclerotic cardiovascular disease.
Watch